- Home
- COYA vs RMI Comparison
COYA vs RMI Comparison
Compare COYA & RMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- RMI
- Stock Information
- Founded
- COYA 2020
- RMI 2018
- Country
- COYA United States
- RMI United States
- Employees
- COYA N/A
- RMI N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- RMI Finance/Investors Services
- Sector
- COYA Health Care
- RMI Finance
- Exchange
- COYA Nasdaq
- RMI Nasdaq
- Market Cap
- COYA 103.2M
- RMI 88.7M
- IPO Year
- COYA 2022
- RMI N/A
- Fundamental
- Price
- COYA $5.93
- RMI $14.44
- Analyst Decision
- COYA Strong Buy
- RMI
- Analyst Count
- COYA 4
- RMI 0
- Target Price
- COYA $17.00
- RMI N/A
- AVG Volume (30 Days)
- COYA 66.8K
- RMI 17.4K
- Earning Date
- COYA 05-13-2025
- RMI 01-01-0001
- Dividend Yield
- COYA N/A
- RMI 7.28%
- EPS Growth
- COYA N/A
- RMI N/A
- EPS
- COYA N/A
- RMI N/A
- Revenue
- COYA $3,685,107.00
- RMI N/A
- Revenue This Year
- COYA $94.45
- RMI N/A
- Revenue Next Year
- COYA N/A
- RMI N/A
- P/E Ratio
- COYA N/A
- RMI N/A
- Revenue Growth
- COYA N/A
- RMI N/A
- 52 Week Low
- COYA $4.65
- RMI $13.05
- 52 Week High
- COYA $10.24
- RMI $17.37
- Technical
- Relative Strength Index (RSI)
- COYA 48.29
- RMI 49.67
- Support Level
- COYA $5.63
- RMI $14.27
- Resistance Level
- COYA $6.53
- RMI $14.59
- Average True Range (ATR)
- COYA 0.46
- RMI 0.18
- MACD
- COYA -0.03
- RMI 0.04
- Stochastic Oscillator
- COYA 29.70
- RMI 60.61
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About RMI RiverNorth Opportunistic Municipal Income Fund Inc.
RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.